ERBB2 and breast carcinoma: Activating the PIK3CA gene mutation is the most common alteration in breast cancer with different frequency among various subtypes identified more than 70% in luminal tumors, 39% in hormone-independent HER2+, and approximately 9% in TNBC [32,40].